BAKERSFIELD, Calif. — Carlos A. grew up in a family on Medicaid, which made healthcare an afterthought since the public insurance is free for low-income enrollees. But when he received a raise two years ago, he found himself earning too much to qualify for the safety net program. And when he browsed Covered California plans,…
At Chain of Lakes Elementary School in Winter Haven, Florida, Josette Smith’s 9-year-old son, Ethan, gets to do what he loves most: crafts, math, and science. That is, when he isn’t being pulled out of class. Ethan has autism and attention-deficit/hyperactivity disorder. He was diagnosed with autism in kindergarten after displaying behavior that concerned his…
Last year, Stephanie Halver’s primary care doctor consulted a risk assessment tool to calculate her chances of one day developing breast cancer. Halver, now 43, remembered the likelihood “popped up really high.” That’s partly because Halver’s mother and aunt have had breast cancer. Her age and dense breast tissue also put her at higher risk….
A new class action lawsuit accuses Oura of overstating its smart ring’s sleep tracking accuracy, arguing the device relies on AI-generated estimates rather than the clinical measurements needed for true sleep staging. The case is reigniting questions about how much precision consumers should expect from AI-powered health wearables. The post Why Oura’s Sleep-Tracking Lawsuit Is…
Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs. The post Business Group on Health: Employer Healthcare Costs Projected to Rise 9.2% in 2027 appeared first on MedCity News.
Johnson & Johnson antibody drug Imaavy expanded its label to include the treatment of warm autoimmune hemolytic anemia (wAIHA). Projected to become a blockbuster seller across multiple indications, Imaavy was first approved last year for treating generalized myasthenia gravis. The post J&J’s Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia appeared first on…
Stakeholders argue that proposed rule would cause disruption for over 1 million Medicare beneficiaries who rely on remote monitoring to manage chronic conditions
Some rural hospital leaders are hesitant to even apply for CMS Rural Health Transformation funds because they lack the administrative resources to apply, manage reporting requirements and demonstrate long-term results. And failure to meet those requirements could jeopardize continued funding or trigger repayment.
Here’s how finance leaders can evaluate AI investments in revenue cycle management before committing budget, and the risk exposure most vendor pitches leave out. The post Before You Sign That AI Contract: 7 Questions Every Healthcare CFO Should Ask appeared first on MedCity News.
In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn’t afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug….